Rodeo Therapeutics has developed therapies to regenerate tissue, based on research undertaken at Case Western Reserve University and University of Texas Southwestern Medical Center.

US-based small-molecule therapy developer Rodeo Therapeutics Corporation raised $5.9m in series A financing yesterday from investors including pharmaceutical firms AbbVie, Eli Lilly, Johnson & Johnson and WuXi AppTec.

The round also featured Alexandria Venture Investments, the venture capital vehicle for real estate investment trust Alexandria Real Estate Equities, investment manager Accelerator Corporation, Arch Venture Partners, Watson Fund and WRF Capital.

AbbVie and Johnson & Johnson participated in the round through their respective corporate venturing units, AbbVie Ventures and Johnson &…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?